Broadcom
AVGO
Alphabet-C
GOOG
Alphabet-A
GOOGL
Salesforce
CRM
Tesla
TSLA
US Stock MarketDetailed Quotes
BRNS Barinthus Biotherapeutics
- 0.920
- -0.020-2.12%
Trading Dec 11 10:46 ET
37.01MMarket Cap-0.62P/E (TTM)
0.930High0.920Low8.75KVolume0.920Open0.940Pre Close8.06KTurnover0.03%Turnover RatioLossP/E (Static)40.23MShares4.15952wk High0.23P/B25.92MFloat Cap0.81052wk Low--Dividend TTM28.17MShs Float17.990Historical High--Div YieldTTM1.06%Amplitude0.810Historical Low0.920Avg Price1Lot Size
Barinthus Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -62.61%-18.2M | 29.20%-12.01M | -272.46%-11.82M | -252.89%-50.93M | -72.82%-19.6M | -194.17%-11.19M | -102.04%-16.96M | 51.76%-3.17M | 55.71%-14.43M | -42.29%-11.34M |
| Net income from continuing operations | 42.39%-8.13M | 28.88%-16.94M | 14.83%-15.52M | -1,480.32%-73.45M | 18.30%-17.29M | -271.63%-14.11M | -251.85%-23.82M | -807.96%-18.22M | 110.41%5.32M | -39.50%-21.16M |
| Operating gains losses | 141.73%2.61M | -87.76%443K | -129.28%-1.03M | 129.82%7.53M | -43.01%6.65M | 65.69%-6.24M | --3.62M | --3.5M | -432.89%-25.25M | --11.67M |
| Depreciation and amortization | 0.07%1.48M | 12.93%1.47M | 17.12%1.43M | 25.58%5.43M | 21.92%1.44M | 24.07%1.47M | 30.95%1.3M | 26.40%1.22M | 618.11%4.32M | 266.67%1.18M |
| Deferred tax | 99.50%-3K | 99.38%-7K | 92.83%-37K | 29.10%-3.08M | 57.55%-821K | 3.68%-602K | -24.15%-1.14M | 40.21%-516K | -3,544.54%-4.34M | -3,292.98%-1.93M |
| Other non cash items | 108.33%2K | -30.87%383K | 18.41%431K | 21.43%1.41M | 191.18%517K | -104.17%-24K | -28.15%554K | -4.96%364K | 0.96%1.16M | -262.93%-567K |
| Change In working capital | -285.20%-15.29M | 168.63%1.46M | -84.43%1.29M | 211.71%6.17M | -323.42%-10.88M | -57.91%8.26M | 106.06%542K | 160.59%8.25M | 23.04%-5.52M | -185.47%-2.57M |
| -Change in receivables | -1,510.14%-15.55M | 429.46%683K | -104.69%-331K | 221.35%5.67M | -270.68%-553K | -108.30%-966K | -68.69%129K | 141.42%7.06M | -53.38%-4.68M | 145.06%324K |
| -Change in prepaid assets | -14.99%1.82M | -64.09%-1.61M | -54.16%1.88M | 201.38%2.2M | -491.40%-3.05M | -30.25%2.14M | 79.93%-983K | 464.85%4.09M | 48.59%-2.17M | -38.81%779K |
| -Change in payables and accrued expense | -131.23%-2.28M | 150.11%3.45M | 55.43%-1.35M | -173.24%-1.39M | -112.12%-7.04M | 48.21%7.29M | 132.26%1.38M | -166.14%-3.02M | 112.71%1.89M | -235.00%-3.32M |
| -Change in other current assets | --0 | --0 | --0 | 133.07%128K | 193.06%201K | ---211K | 108.98%15K | 3,175.00%123K | 47.35%-387K | -2,063.64%-216K |
| -Change in other current liabilities | ---487K | ---473K | ---346K | ---445K | ---445K | --0 | --0 | --0 | --0 | ---- |
| -Change in other working capital | --1.21M | ---595K | --1.43M | ---- | ---- | ---- | ---- | ---- | -190.48%-183K | -833.33%-140K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -62.61%-18.2M | 29.20%-12.01M | -272.46%-11.82M | -252.89%-50.93M | -72.82%-19.6M | -194.17%-11.19M | -102.04%-16.96M | 51.76%-3.17M | 55.71%-14.43M | -42.29%-11.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | 55.47%-5.75M | 95.19%-586K |
| Net PPE purchase and sale | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | -401.75%-5.75M | -38.21%-586K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | 55.47%-5.75M | 95.19%-586K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 910.87%465K | 1,178.57%358K | -70.22%503K | 476.00%1.87M | -77.48%109K | 46K | 28K | 1,162.26%1.69M | -99.85%325K | 5,277.78%484K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---159K | --0 |
| Net common stock issuance | 910.87%465K | 293.41%358K | -71.88%503K | 320.45%2.04M | -77.48%109K | --46K | --91K | --1.79M | -99.53%484K | 268.64%484K |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---163K | --0 | --0 | ---63K | ---100K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 910.87%465K | 1,178.57%358K | -70.22%503K | 476.00%1.87M | -77.48%109K | --46K | --28K | 1,162.26%1.69M | -99.85%325K | 5,277.78%484K |
| Net cash flow | ||||||||||
| Beginning cash position | -31.93%117.77M | -32.07%129.97M | -26.90%142.09M | -9.19%194.39M | -19.89%160.31M | -10.03%173.03M | -4.62%191.33M | -9.19%194.39M | 394.74%214.05M | -14.44%200.1M |
| Current changes in cash | -59.62%-17.85M | 40.66%-11.84M | -191.26%-11.63M | -174.30%-54.47M | -68.99%-19.34M | -213.33%-11.18M | -90.98%-19.95M | 49.02%-3.99M | -111.20%-19.86M | 43.21%-11.45M |
| Effect of exchange rate changes | 500.97%6.18M | -121.58%-357K | -152.62%-492K | 1,060.96%2.17M | -80.41%1.12M | 26.28%-1.54M | -24.06%1.65M | 116.61%935K | 102.90%187K | 1,604.17%5.73M |
| End cash Position | -33.81%106.1M | -31.93%117.77M | -32.07%129.97M | -26.90%142.09M | -26.90%142.09M | -19.89%160.31M | -10.03%173.03M | -4.62%191.33M | -9.19%194.39M | -9.19%194.39M |
| Free cash flow | -63.11%-18.31M | 38.95%-12.2M | -113.52%-12.13M | -173.90%-56.34M | -63.05%-19.45M | -218.45%-11.23M | -91.25%-19.98M | 25.94%-5.68M | 39.02%-20.57M | -42.08%-11.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.